Morningstar•January 11, 2021

Tilray, Inc.: All Cannabis Stocks Rally From Senate Results, but Actual Economic Exposure Differs Widely

Symbols

TLRY

Sector(s)

Healthcare

Rating

Premium

Current Price

$24.36

Fair Value

Premium

Economic Moat

Premium

Stewardship

Premium

Summary

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray’s sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Premium

Subscribe to Yahoo Finance Premium for full access

Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.

Try Premium FREE

Actions

Download Full Report

Related Reports

View more related reports

Analyst Profile

Kristoffer Inton

Director

Kristoffer Inton is director of equity research, basic materials for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He covers gold, aggregates and cement, and uranium companies.Before joining Morningstar in 2013, Inton was an investment banking associate for Guggenheim Securities in New York. Previously, he was an investment banking analyst for Merrill Lynch in Chicago and New York.Inton holds a bachelor’s degree in finance with high honors from the University of Illinois and a master’s degree in business administration with distinction from Northwestern University’s Kellogg School of Management.